230 related articles for article (PubMed ID: 27377765)
1. Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases.
Jurczyluk J; Munoz MA; Skinner OP; Chai RC; Ali N; Palendira U; Quinn JM; Preston A; Tangye SG; Brown AJ; Argent E; Ziegler JB; Mehr S; Rogers MJ
Immunol Cell Biol; 2016 Nov; 94(10):994-999. PubMed ID: 27377765
[TBL] [Abstract][Full Text] [Related]
2. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.
Munoz MA; Jurczyluk J; Simon A; Hissaria P; Arts RJW; Coman D; Boros C; Mehr S; Rogers MJ
Front Immunol; 2019; 10():1900. PubMed ID: 31474985
[TBL] [Abstract][Full Text] [Related]
3. Unprenylated RhoA contributes to IL-1β hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity.
van der Burgh R; Pervolaraki K; Turkenburg M; Waterham HR; Frenkel J; Boes M
J Biol Chem; 2014 Oct; 289(40):27757-65. PubMed ID: 25107911
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases.
Dunford JE; Rogers MJ; Ebetino FH; Phipps RJ; Coxon FP
J Bone Miner Res; 2006 May; 21(5):684-94. PubMed ID: 16734383
[TBL] [Abstract][Full Text] [Related]
5. A highly sensitive prenylation assay reveals in vivo effects of bisphosphonate drug on the Rab prenylome of macrophages outside the skeleton.
Ali N; Jurczyluk J; Shay G; Tnimov Z; Alexandrov K; Munoz MA; Skinner OP; Pavlos NJ; Rogers MJ
Small GTPases; 2015 Oct; 6(4):202-11. PubMed ID: 26399387
[TBL] [Abstract][Full Text] [Related]
6. Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.
Politiek FA; Waterham HR
Front Immunol; 2021; 12():724991. PubMed ID: 34539662
[TBL] [Abstract][Full Text] [Related]
7. A role for geranylgeranylation in interleukin-1beta secretion.
Mandey SH; Kuijk LM; Frenkel J; Waterham HR
Arthritis Rheum; 2006 Nov; 54(11):3690-5. PubMed ID: 17075828
[TBL] [Abstract][Full Text] [Related]
8. Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency.
Henneman L; Schneiders MS; Turkenburg M; Waterham HR
J Inherit Metab Dis; 2010 Oct; 33(5):625-32. PubMed ID: 20814828
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular consequences of mevalonate kinase deficiency.
Politiek FA; Turkenburg M; Henneman L; Ofman R; Waterham HR
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167177. PubMed ID: 38636615
[TBL] [Abstract][Full Text] [Related]
10. Increased core body temperature exacerbates defective protein prenylation in mouse models of mevalonate kinase deficiency.
Munoz MA; Skinner OP; Masle-Farquhar E; Jurczyluk J; Xiao Y; Fletcher EK; Kristianto E; Hodson MP; O'Donoghue SI; Kaur S; Brink R; Zahra DG; Deenick EK; Perry KA; Robertson AA; Mehr S; Hissaria P; Mulders-Manders CM; Simon A; Rogers MJ
J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 36189795
[TBL] [Abstract][Full Text] [Related]
11. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation.
Normand S; Massonnet B; Delwail A; Favot L; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
Eur Cytokine Netw; 2009 Sep; 20(3):101-7. PubMed ID: 19825518
[TBL] [Abstract][Full Text] [Related]
12. Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency.
Tricarico PM; Romeo A; Gratton R; Crovella S; Celsi F
Cell Physiol Biochem; 2017; 41(4):1649-1660. PubMed ID: 28359055
[TBL] [Abstract][Full Text] [Related]
13. Mevalonate kinase-deficient THP-1 cells show a disease-characteristic pro-inflammatory phenotype.
Politiek FA; Turkenburg M; Ofman R; Waterham HR
Front Immunol; 2024; 15():1379220. PubMed ID: 38550596
[TBL] [Abstract][Full Text] [Related]
14. The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.
Marcuzzi A; De Leo L; Decorti G; Crovella S; Tommasini A; Pontillo A
Pediatr Res; 2011 Jul; 70(1):78-82. PubMed ID: 21430599
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation.
Kuijk LM; Beekman JM; Koster J; Waterham HR; Frenkel J; Coffer PJ
Blood; 2008 Nov; 112(9):3563-73. PubMed ID: 18684863
[TBL] [Abstract][Full Text] [Related]
16. Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome.
Politiek FA; Turkenburg M; Koster J; Ofman R; Waterham HR
J Inherit Metab Dis; 2024 Mar; 47(2):302-316. PubMed ID: 38131282
[TBL] [Abstract][Full Text] [Related]
17. Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1.
Kuijk LM; Mandey SH; Schellens I; Waterham HR; Rijkers GT; Coffer PJ; Frenkel J
Mol Immunol; 2008 Apr; 45(8):2158-65. PubMed ID: 18242710
[TBL] [Abstract][Full Text] [Related]
18. Temperature and drug treatments in mevalonate kinase deficiency: an ex vivo study.
Tricarico PM; Kleiner G; Piscianz E; Zanin V; Monasta L; Crovella S; Marcuzzi A
Biomed Res Int; 2013; 2013():715465. PubMed ID: 24073415
[TBL] [Abstract][Full Text] [Related]
19. 25-Hydroxycholesterol and inflammation in Lovastatin-deregulated mevalonate pathway.
Tricarico PM; Gratton R; Braga L; Celsi F; Crovella S
Int J Biochem Cell Biol; 2017 Nov; 92():26-33. PubMed ID: 28918367
[TBL] [Abstract][Full Text] [Related]
20. Regulatory adaptation of isoprenoid biosynthesis and the LDL receptor pathway in fibroblasts from patients with mevalonate kinase deficiency.
Hoffmann GF; Wiesmann UN; Brendel S; Keller RK; Gibson KM
Pediatr Res; 1997 Apr; 41(4 Pt 1):541-6. PubMed ID: 9098857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]